Seven Grand Managers’s HilleVax HLVX Stock Holding History

Seven Grand Managers’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,845	Closed	-$200K	–	43
2023 Q3	$200K	Buy	+14,845	New	+$209K	0.27%	27
2022 Q3	–	Sell	-34,386	Closed	-$376K	–	26
2022 Q2	$376K	Buy	+34,386	New	+$408K	0.85%	24

Other funds holding HLVX

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Seven Grand Managers's HLVX Position: Q4 2023 in Review

Seven Grand Managers sold out of HilleVax (HLVX) in Q4 2023, closing a stake of 14,845 shares — an estimated $200K sold.

Seven Grand Managers first reported a position in HLVX in Q2 2022 and held it in 2 quarters. The position peaked at $376K in Q2 2022. 69 funds tracked by Wall St. Rank hold HLVX as of Q4 2023.

Seven Grand Managers reported no remaining HilleVax position as of Q4 2023 after selling out during the quarter.
Seven Grand Managers sold 14,845 HilleVax shares in Q4 2023, an estimated $200K.
Seven Grand Managers first reported a position in HilleVax in Q2 2022 and held it in 2 quarters.
Seven Grand Managers's HilleVax position peaked at $376K in Q2 2022.
69 funds tracked by Wall St. Rank held HilleVax as of Q4 2023.

Based on Seven Grand Managers's 13F filing for Q4 2023, filed 7 Feb 2024.